Routes of
administration Oral CAS Number 59170-23-9 Molar mass 345.43 g/mol | ATC code C07AB06 (WHO) PubChem CID 2372 | |
 | ||
AHFS/Drugs.com International Drug Names Legal status unapproved, never marketed | ||
Bevantolol (INN) was a drug candidate for angina and hypertension that acted as both a beta blocker and a calcium channel blocker. It was discovered and developed by Warner-Lambert but in January 1989 the company announced that it had withdrawn the New Drug Application; the company's chairman said: "Who needs the 30th beta blocker?" As of 2016 it wasn't marketed in the US, UK, or Europe and the authors of a Cochrane review could find no product monograph for it.
References
Bevantolol Wikipedia(Text) CC BY-SA